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SUPPLEMENTARY NOTES
ABSTRACT
Evidence for a genetic component to prostate cancer is strong, however few genes have been identified, and most of the genetic risk remains undefined. To date, multiple traditional genome scans have been performed, and several susceptibility loci have been identified. Traditional genome scans using familial data have generally not included enough African Americans to provide adequate statistical power to detect linkage. Our project uses a novel approach to gene discovery with greater power to detect genetic effects, admixture mapping, to identify prostate cancer susceptibility loci in a sample of African American men. Freedman et al. reported a susceptibility region on chromosome 8q24, detected by admixture mapping in 1,597 African American men. In the current study, approximately 800 samples from 2 case-control study of prostate cancer were genotyped for ancestry informative markers across the genome. Admixture mapping analyses were performed using ADMIXMAP and ANCESTRYMAP statistical programs. The prostate cancer susceptibility locus on 8q24 identified by Freedman et al. was confirmed, with a peak lod score estimated using ANCESTRYMAP of 1.54 between markers rs12547950 and rs4367565. A new prostate cancer susceptibility locus on chromosome 5q35 was identified, with a maximum lod score of 3.16 detected at marker rs7729084 using ADMIXMAP. This new region is actively being explored via fine mapping and candidate gene approaches. The goal of this research proposal is to use a novel approach to gene discovery, admixture mapping, to identify potential prostate cancer susceptibility genes in a group of African American men. Admixture mapping has greater power to detect genetic effects than traditional genome linkage scans. Recently, Freedman et al. published results from an admixture mapping study of prostate cancer in 1,597 African American men which detected a susceptibility region on chromosome 8q24 (1). In the current study, approximately 800 samples from 2 case-control study of prostate cancer were genotyped for ancestry informative markers across the genome, using a similar marker panel to that used by Freedman et al. The admixture mapping analyses were performed using ADMIXMAP (2, 3) and ANCESTRYMAP (4) statistical programs. Regions showing strong linkage using the admixture mapping approach will be followed by future studies using fine mapping with a denser set of informative markers in the regions of interest and candidate gene studies.
SUBJECT TERMS
BODY:
The details of progress within each Task are as follows.
Task 1. To obtain genotype information for all study subjects (Months 1-18): a. Prepare batches of DNA and ship to ParAllele, starting with samples from controls (Months 1-17). b. ParAllele to perform Genotyping and transmit results to Dr. Bock (Months 2-18).
DNA samples for 520 cases and 287 controls were prepared for genotyping, and shipped to the laboratory. In addition to the 351 cases and 95 controls from HFHS, we also included 456 cases and 192 controls from Dr. Rick Kittles' prostate cancer case control study (described in Bonilla et al., (5) The ADMIXMAP software was successfully set up on a local computer, and the PI successfully ran a test data set through the program. After some preliminary data cleaning, the data was sent to Dr. David Reich at the Broad Institute and he performed further data quality checks and performed admixture analysis using his ANCESTRYMAP program. After receiving the cleaned data back from Dr. Reich, we used the ADMIXMAP program to repeat the admixture analyses. ADMIXMAP is less conservative than ANCESTRYMAP, and therefore more likely to detect linked regions. The more conservative ANCESTRYMAP, however, provides estimates of linkage at loci between the genotyped markers and thus a more precise estimate of the location of a susceptibility locus. The results of both methods were consistent with each other with regard to the location of peak lod scores within the genotyped markers.
After data cleaning, there were 520 cases and 287 controls eligible for inclusion in the data. Reasons for exclusion included poor genotype quality and duplicate samples (several men had apparently enrolled in >1 of 3 Howard University studies that provided blinded samples).
Results from both ADMIXMAP and ANCESTRYMAP confirm linkage to the region on chromosome 8p (Supporting Data, Additionally, linkage to a new region on chromosome 5q35 (Supporting Data, Figure 2 ) was detected in our study population. Using ADMIXMAP, the peak lod score was 3.16 at marker rs7729084. Similarly, the peak lod score on chromosome 5 identified by ANCESTRYMAP was 2.07 at this same marker. We are in the process of identifying candidate genes in this region and also preparing to perform fine mapping in an independent sample of prostate cancer cases and controls.
We are currently running admixture mapping analyses stratifying by age at diagnosis and prostate cancer stage and grade for inclusion in our manuscript.
Task 3. Final Analyses and Report Writing, Months 20-24: a. A final report describing the mapping findings and any gene-environment interactions will be prepared (months 20-24).
Preliminary findings were presented in an abstract (see Appendix) and poster at the 2007 IMPaCT meeting in Atlanta, GA. The genomewide results are summarized in Figure 3 (see Supporting Data). The final manuscript is currently being prepared for submission to a peer-reviewed journal.
KEY RESEARCH ACCOMPLISHMENTS:
• Genomewide genotype data was generated for xx prostate cancer cases and xx controls.
• Genomewide admixture mapping was performed on these samples using ANCESTRYMAP and ADMIXMAP programs.
• A prostate cancer susceptibility locus on chromosome 8q24 was confirmed.
• A new prostate cancer susceptibility locus on chromosome 5q35 was identified, with a maximum lod score of 3.16 detected at marker rs7729084.
• Preliminary results were presented at the 2007 IMPaCT meeting in abstract and poster form.
REPORTABLE OUTCOMES:
A database of genotype information on 745 African American men has been established. Preliminary findings were presented in an abstract (see Appendix) and poster at the 2007 IMPaCT meeting in Atlanta, GA. The genomewide results are summarized in Figure 3 (see Supporting Data). The final manuscript is currently being prepared for submission to a peer-reviewed journal.
CONCLUSION:
The presence of a prostate cancer susceptibility locus on 8q24 was confirmed, with a peak lod score of 1.54 between markers rs12547950 and rs4367565 estimated using ANCESTRYMAP. A new prostate cancer susceptibility locus on chromosome 5q35 was identified, with a maximum lod score of 3.16 detected at marker rs7729084 using the ADMIXMAP statistical program. This new region is actively being explored via fine mapping and candidate gene approaches. Evidence for a genetic component to prostate cancer risk is strong, however few genes have been identified, and most of the genetic risk remains undefined. To date, multiple traditional genome scans and linkage analyses have been performed, and several susceptibility loci and candidate genes have been identified. This research project used a novel approach to gene discovery, admixture mapping, to identify potential prostate cancer susceptibility genes in a sample of African American men from two case-control studies of prostate cancer. The admixture mapping method has greater power to detect genetic effects than traditional genome linkage scans. Recently, Freedman et al. published results from an admixture mapping study of prostate cancer in 1,597 African American men which detected a susceptibility region on chromosome 8q24 (PNAS 103(38) 14068-73). In the current study, samples from 520 cases and 287 controls have been genotyped for 1,536 ancestry informative markers from across the genome, using an updated version of the marker panel used by Freedman et al. Genotyping was performed using a custom array on the Illumina BeadStation platform using GoldenGate assay technology. At the time of abstract submission, all genotyping has been completed and data cleaning and analyses using ANCESTRYMAP and ADMIXMAP software programs are underway; preliminary results will be available by the end of April. Regions showing strong linkage using the admixture mapping approach will be followed up using fine mapping with a denser set of informative markers in the regions of interest and/or candidate gene studies. The goal of this project is to identify genomic prostate cancer susceptibility loci in a sample of African American men which can then lead to the identification of genes associated with increased prostate cancer risk; ultimately, this genetic information will be used to identify high risk individuals, and will improve screening techniques and prevention targeting efforts. SUPPORTING DATA: 
